The potential of induced pluripotent stem cells for discriminating neurodevelopmental disorders

Studying human disease-specific processes and mechanisms in vitro is limited by a lack of valid human test systems. Induced pluripotent stem cells (iPSCs) evolve as an important and promising tool to better understand the molecular pathology of neurodevelopmental disorders. Patient-derived iPSCs enable analysis of unique disease mechanisms and may also serve for preclinical drug development. Here, we review the current knowledge on iPSC models for schizophrenia and autism spectrum disorders with emphasis on the discrimination between them. It appears that transcriptomic analyses and functional read-outs are the most promising approaches to uncover specific disease mechanisms in vitro.

Automated summary

Patient-derived iPSCs are a valuable tool for studying unique disease mechanisms and potential preclinical drug development. Transcriptomic analyses and functional read-outs are the most promising approaches for uncovering specific disease mechanisms in vitro.